|
||
|
|
PRL-8-53 is a synthetic Nootropic supplement, meaning it was created in a lab. Its full name is methyl 3-(2-(benzyl(methyl)amino)ethyl)benzoate.
PRL-8-53 Overview
PRL-8-53 is a nootropic research compound first synthesized in the 1970’s by Dr Nikolaus Hansl while working at Creighton University. The compound takes its name from creator’s company Pacific Research Labs (3) who were also the (now expired) patent holders (3). Very little research on this compound is available online. What is available appears to have been conducted by the old patent holder.
PRL-8-53 Study
Researchers found that oral supplementation of PRL-8-53 was able to improve avoidance learning in rats. One human study has also been done on PRL-8-53. Each participant ingested a placebo and PRL-8-53, at separate times, in a double blind crossover study. Participants then took a memory test, consisting of twelve monosyllabic words in a particular order. The test was conducted three times, immediately after supplementation, one day after supplementation, and four days after supplementation.
People
that remembered more than eight words after taking a placebo experienced minor
benefits, but people over 30 or with poor short term memory benefitted greatly
from supplementation. In some cases, their score on the word test doubled.
PRL-8-53 Dosage
More evidence is needed to determine the ideal
dosage for PRL-8-53. The effective dosage may vary, since the only human study
on PRL-8-53 used a single dose of 5mg, while patent information on PRL-8-53
suggests a dosage range of 0.01-4mg/kg, with an 'ideal' range of 0.05-1.2mg/kg.
PRL-8-53 Side Effects
No side effects were observed in the human study, and preliminary rodent evidence suggests PRL-8-53 is safe. Using PRL-8-53 as a dietary supplement, however, cannot be recommended at this time because it is a synthetic substance and all of the evidence for its effects comes from studies funded by the holder of the patent.
More details, please visit our website www.koffeepharm.com
Koffee Pharm Co., Ltd.